Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sapna Palep

Dermatology New York, NY Medical Doctor

NPI 1104084334 CMS profile 878325

75 Spring St Fl 2, New York, NY 10012

Open in the dashboard

General payments

$85,563

433 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sapna Palep of New York, NY is reported in the CMS Open Payments database as having received $85,563 across 433 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,112 51
2024 General $9,616 27
2023 General $30,332 59
2022 General $10,120 33
2021 General $4,399 94
2020 General $16,430 75
2019 General $8,554 94

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sapna Palep
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Sapna Palep were reported at $6,112. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Sapna Palep Dermatology median Middle half National median
2019 $8,554 $454 $129–$1,240 $163
2020 $16,430 $235 $81–$756 $114
2021 $4,399 $377 $108–$1,108 $132
2022 $10,120 $514 $143–$1,391 $149
2023 $30,332 $607 $159–$1,674 $160
2024 $9,616 $751 $204–$1,903 $164
2025 $6,112 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Galderma Laboratories, L.P. $77,511 103 payments
  2. AbbVie, Inc. $2,134 45 payments
  3. Pfizer Inc. $937 50 payments
  4. Allergan Inc. $608 36 payments
  5. Ortho Dermatologics, a division of Bausch Health US, LLC $503 28 payments
  6. Regeneron Healthcare Solutions, Inc. $483 16 payments
  7. Incyte Corporation $468 29 payments
  8. Janssen Biotech, Inc. $384 18 payments
  9. LEO Pharma Inc. $253 11 payments
  10. Sun Pharmaceutical Industries Inc. $239 11 payments
  11. Other $2,044 86 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $70,182 16 payments
  2. Food and Beverage $11,936 393 payments
  3. Travel and Lodging $2,089 14 payments
  4. Consulting Fee $1,200 1 payment
  5. Education $155 9 payments
Products named General payments · program years 2019–2025
  1. AKLIEF $24,069 47 payments
  2. EPIDUO FORTE $14,663 31 payments
  3. TWYNEO $10,423 13 payments
  4. BOTOX $1,621 21 payments
  5. LITFULO $560 32 payments
  6. ORACEA $538 13 payments
  7. EUCRISA $520 30 payments
  8. CIBINQO $486 27 payments
  9. OPZELURA $468 29 payments
  10. DUPIXENT $371 13 payments
  11. Other $5,845 276 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

433 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record